obesity treatment with bariatric surgery vs glp-1 receptor agonists GLP1 (2025): Bariatric Surgery vs Receptor Agonists, ., ⛔️Disclaimer: This post is for educational and informational purposes only Cost effectiveness of GLP-1 s
Description
Schauer, D
Obesity 28 , 122131 (2020)
-(1).png?sfvrsn=c236e848_3)
placebo used an equivalent titration schedule Reduction in heavy drinking days at 26 weeks
The preference for SGLT2i is due to more robust evidence regarding renal outcomes
Furthermore, their use in cardiovascular conditions is also being researched
SNAC, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate
